Profit growth solid but credit stress rising; growth guidance at risk
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Reiterated all FY27 targets (branches 40–45, spreads >6%, credit cost 40–50 bps, growth 25–30%). Prior years' guidance mostly delivered, but Q1 Stage 3 rise (+30 bps) is new deterioration; track record solid but near-term execution at risk.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Solid PAT growth (19.7% YoY, ₹143 Cr) and maintained ROE (17.5%) show operational strength, but rising Stage 3 (1.5%, +30 bps), collection efficiency at decade low (97%), and disbursement growth (18%) lagging peers (30–40%) raise credit and growth execution risks. FY27 guidance maintained but credibility dependent on Q2–Q3 stabilization.
₹432.4 Cr
Revenue · +19.7% YoY₹143 Cr
Reported PAT · +19.7% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
PAT grew 20% YoY; 4% QoQ
METDelivered ₹143 Cr, 19.7% YoY (CFO stated 20%, rounding variance); QoQ 3.9%
Disbursement growth 20%+ on check realization basis achievable
OVERSTATEDQ1 18% growth; peers at 30–40%. July ₹400 Cr cited but annualized ~₹1.6B vs ₹2B needed for 25% AUM growth
Collection efficiency 97%, seasonal Q1 dip normal
MISS97% is decade low; April 96.2%, same as prior year April. Overall trend deteriorating from ~98%+ prior years
No P&L impact from accounting change; interest already provided
METCFO confirmed disbursement timing shifted but interest recognized on check clearance since May 2024 rule
Stage 3 to stabilize Q2, recovery Q3+, breaking historical pattern
UnverifiedStage 3 at 1.5% (+30 bps). Analysts noted Q2 historically sees rises, not flats. Claim is forward-looking, unverified vs past patterns
Earnings quality
What changed since the last call
Asset quality deterioration
DowngradeStage 3 at 1.5% (+30 bps), 30+ at 5.2% (vs sub-3% historically). Prior guidance made no mention; Q1 reveals new weakness despite 24% AUM growth.
Collection efficiency at decade low
DowngradeQ1 at 97%, April 96.2%; prior years >98%. Suggests portfolio stress emerging; not just seasonality.
Disbursement growth slower than peers
Downgrade18% YoY (check realization basis) vs peers 30–40%. Q1 zero branch additions vs annual target 40–45; management deferred branch opens to Q2–Q3.
Accounting methodology change
NeutralCheck handover to check realization; ₹405 Cr timing impact. No P&L effect but creates reporting noise masking underlying slowdown.
The Q&A
Analysts pressed hard on credit deterioration (Umang Shah, Nilesh, Mohak Batra) and growth slowdown (Kunal Shah, Akhil Gulecha). Management defended via seasonality, self-employed stress (1.5–2 yrs), and July strength but didn't fully address why India Shelter is unique vs peers or why collection efficiency is decade-low despite portfolio being 80%+ self-employed (same as years prior). Partial clarity.
AI adoption & measurable value — Aman Soni, Seven Alpha Investors
PartialPartners exist but names confidential. Use cases in vernacular call center, lead triage, turnaround time reduction. No quantified ROI metric disclosed.
Disbursement growth trajectory — Kunal Shah, Citigroup
AnsweredJuly ₹400 Cr disbursement strong, confident 20%+ achievable. Collection efficiency seasonal Q1 dip; expects recovery Q2–Q3 as 30+ delinquency comes down.
Credit quality root cause — Umang Shah, Kotak Mutual Fund
PartialSelf-employed stress (1.5–2 yrs), 80%+ of book. Lower-ticket (₹7L) Stage 3 at 2% vs 1.4% three years back. 1+ metric remains stable (not disclosed). Seasonality + recovery Q3+.
Disbursement accounting impact — Darshan Deora, Indvest Group
AnsweredYes, correct. Reported ₹641 Cr but actual disbursement ₹1,046 Cr; bank clearance ₹1,040 Cr. Accounting change reflects true economics, no P&L impact.
Competitive stress comparison — Mohak Batra, Goldman Sachs
PartialCollection team increased & scattered 2–3 qtrs back across geographies. Self-employed stress (1.5–2 yrs, same as MFI period). Seasonal Q1. No internal deficiency.
Collection efficiency monthly detail — Nilesh, Goldman Sachs
AnsweredApril 96.2–96.4%, May ~96–97%, June 97.5%. Prior April also 96.2%; seasonal pattern. Expects improvement Q2.
Stage 3 stabilization vs historical pattern — Nilesh, Goldman Sachs
AnsweredYes, Q2 flat, Q3 recovery. Stress spike came early (Q1) this year vs Q3 last year; different seasonal timing of delinquency flows.
July disbursement sustainability — Renish Bhuva, ICICI Securities
AnsweredConfident; July strong despite monsoon. Q2 ₹1,200 Cr reachable, Q3 better. 20%+ disbursement = 25–30% AUM; numbers speak.
Guidance
FY27 AUM growth 25–30%
MediumQ1 at 24% impacted by ₹405 Cr accounting shift. Management confident July ₹400 Cr run-rate will drive acceleration. Disbursement growth needs 20%+ rest of year.
Maintain spreads >6% medium-term
HighPortfolio yield 14.8% stable, finance cost 8.2% stable. Incremental yield 14.9% provides cushion. Cost-to-income 36%, OpEx 4%; both stable.
Branch additions 40–45 for FY27
MediumZero branches Q1; timing shifted to Q2–Q3. Management says 160 employees added Q1 for collections & tech, not branches. Acceleration needed Q2 onwards.
Risks the call surfaced
Credit quality deterioration
HighStage 3 at 1.5% (+30 bps YoY), 30+ at 5.2% vs sub-3% historically. 80%+ of portfolio self-employed, under stress 1.5–2 yrs. Collection efficiency 97%, lowest on record.
Collection infrastructure maturation lag
MediumCollection team scattered across geographies 2–3 qtrs back; efficiency still recovering (97% in Q1, April 96.2%). Risk of Stage 3 persistence longer than guided.
Growth deceleration vs peers
MediumDisbursement growth 18% YoY (check realization basis) vs peers 30–40%. AUM growth 24% vs guidance 25–30%. Q1 zero branch additions; deferred to Q2–Q3.
Macro borrowing cost pressure
LowBankers asking 20–25 bps higher cost; management expects overall impact +10 bps H2. Incremental yield raised 30 bps to offset; risk of spread compression if tightness persists.
Management
Score 6/10. Transparent on accounting change (₹405 Cr timing, no P&L impact), specific on July disbursements (₹400 Cr), but evasive on root cause of credit deterioration. Admitted self-employed stress but didn't explain why peers aren't seeing similar stress. Withheld AI vendor names citing confidentiality. Delivered solid PAT growth (19.7% YoY, ₹143 Cr) and held ROE (17.5%), but missed growth velocity (24% AUM vs 25–30% guidance) and allowed credit metrics to deteriorate (Stage 3 +30 bps, efficiency 97%). Track record strong but Q1 shows new weakness.
1 · Q2 FY27 (Sep 2026)
Collection efficiency recovery & Stage 3 stabilization; critical test of management's Q1-is-anomaly narrative
2 · Q3 FY27 (Dec 2026)
Stage 3 recovery & SARFAESI resolution begin; management expects 30+ delinquency decline & credit cost moderation
3 · Jul–Aug 2026
Disbursement run-rate ₹400 Cr/month confirmed; if sustained, supports 20%+ growth & 25–30% AUM target
FY27 guidance maintained but credibility dependent on Q2–Q3 stabilization.
Informational and educational content only. Not investment advice.